+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

China Top 60 Biopharmaceutical Manufacturing Directory

  • ID: 4769061
  • Directory
  • February 2017
  • Region: China
  • 357 Pages
  • Bioplan Associates Inc
1 of 4

FEATURED COMPANIES

  • 3SBio
  • Chengdu Institute
  • Hisun
  • Lanzhou Institute
  • Shanghai Pharma
  • Teruisipharm
  • MORE

The completely updated, comprehensive Top 60 Directory provides detailed profiles of China biopharmaceutical facilities, including information on their capacity, history, products, scale, management, business focus, products, R&D, business and partnering strategies, strengths and weaknesses, and future objectives. The directory also highlights current and upcoming facilities, and includes information on key marketed and clinical trial products.

Top 60 Biopharmaceutical Facilities in China Directory allows readers to keep up-to-date on new and existing biopharmaceutical facilities as the industry continues to grow and expand. This newly updated directory helps you stay aware of current key participants, as well as new and upcoming facilities in this rapidly changing market.

Directory Content

Ranking of Most Important Facilities: Greatest capacity, staff, suites and production facilities:

  • Total liters’ capacity
  • Capacity under active construction
  • Number of employees related to biologics production
  • Number of product in commercial or clinical production
  • Ownership, management history, financial estimates, size, partnerships, etc.
  • Much more...
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3SBio
  • Chengdu Institute
  • Hisun
  • Lanzhou Institute
  • Shanghai Pharma
  • Teruisipharm
  • MORE

Chapter 1 China Biopharmaceutical Manufacturing

Chapter 2 Study Methodology
Table 1: Top 60 Biopharmaceutical Companies in China (By Ranking)

Chapter 3 Major Events in China Biopharma
Table 2: Launch of Major Biological Products (Mostly Mab), 2006-2016
Table 3: New Mab Makers and Chemical Drug Makers Entering mAb Sector

Chapter 4 Summary of China Biopharmaceutical Manufacturers
Table 4: China Biopharmas By Facility Primary Manufacture Type

Chapter 5 Profiles of 10 Biopharmaceutical Organizations in China

Appendix: Emerging Biopharma Companies in China

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • 3SBio
  • Chengdu Institute
  • Hisun
  • Lanzhou Institute
  • Shanghai Pharma
  • Teruisipharm
  • MORE

This is the second edition of the facilities directory of major biopharmaceutical manufacturing facilities in China. In it, we cover China’s major biopharmaceutical manufacturing facilities, particularly those with the most bioprocessing capacity (total bioreactor volumes), and those under active construction. Facility information includes company ownership, background, management and facility capacity and history.

This Directory is based on in-depth research, using public secondary and primary information resources. This on-going project is intended to provide in-depth information and insights into the rapidly growing and changing Chinese biologics industry. The original directory, published in March, 2008, included some facilities that have grown rapidly, and some that no longer exist. The landscape in China biopharma has evolved over the past eight years, so much that this update has become urgently necessary.

As the Chinese industry continues to expand, both in technical capabilities and commercial presence, the information in this directory will, necessarily, become outdated. As such, we will have on-staff researchers to keep it up-to-date. However, our readers’ input will be invaluable in that regard. If you have comments or corrections, please forward them to us.

The ranking of companies is based on information publicly available. Factors in ranking each facility include aspects such as liters’ capacity, number of employees related to biologics production, number of products in commercial or clinical production. Financial estimates in some cases are derived from data such as the number of employees, facility size, and available partnership resources.

Because the Chinese biopharmaceutical industry is in a growth phase, some of the organizations profiled are emerging as industry participants. These companies may be included because, based on their human resources, their internal expertise, or their financial capabilities, they have the potential to rapidly enter this market with their own biological products.

Note: Product cover images may vary from those shown
5 of 4
  • Celgene Pharma/Shanghai
  • Livzon mAb
  • Henglius Pharma (a subsidiary of Fosun Pharma)
  • Genor
  • Innovent Bio
  • Teruisipharm
  • Pfizer/Hangzhou
  • Hisun
  • Shanghai Pharma
  • Luye Pharma
  • Huahai Pharma
  • Biotech Pharma
  • AlphaMab
  • CP Guojian Pharmaceutical
  • SinoCellTech
  • Hengrui Pharma/Suzhou
  • Kanghong Pharma
  • Qilu Pharma
  • Tot Pharma
  • Mabtech holding Ltd
  • Simcere Pharma/Yantai
  • Chia Tai Tianqing
  • CSPC Pharma
  • Junshi Pharma/Jiangsu, Suzhou
  • Kelun Pharma
  • Yantai Rongchang (MABPLEX,subsidiary of Yantai Rongchang )
  • ShangPharma (Chempartner)
  • Boehringer-Ingelheim
  • JHL biotech
  • Wuxi Biologics
  • Gan & Lee
  • Jiangsu Wanbang
  • Tonghua DongBao
  • 3SBio
  • Changchun Hi-Tech GeneScience
  • Tasly
  • Sinobioway/Tianjin
  • Zhuhai Essex
  • Anhui Anke Biotechnology
  • Tri-Prime Gene
  • Amoy-Top Biotech (subsidiary of Tonghua Dongbao)
  • SL Pharma / Quebec
  • Shanghai Institute
  • Wuhan Institute
  • Lanzhou Institute
  • Changchun Institute
  • Hualan/Xinxiang
  • Tiantan Biologics
  • Sinovac/Beijing
  • Walvax/Yuxi
  • GSK/Shenzhen
  • Shanghai United Cell/Shanghai
  • North China
  • Sanofi/Shenzhen
  • Benemae Pharmaceutical
  • Generon
  • Zesun Pharma
  • Chengdu Institute
  • Four Rings
  • BeigeneJunshi Pharma / Jiangsu Suzhou
  • ShangPharma (Chempartner)
  • Lee’s Pharma
  • SinoCellTech
  • Simcere Pharma / Jiangsu, Changzhou
  • Kanghong Pharma
  • Changchun Hi-Tech #2 BCHT
  • Huahai Pharma
  • Generon
  • Junshi Pharma / Ligang, Shanghai
  • Luye Pharma
  • Benemae Pharmaceutical
  • Zesun Pharma
  • Beigene
  • Hengrui Pharma / Lianyungang
  • SL Pharma / Beijing
  • Walvax / Kunming
  • Hualan / Beijing
  • Walvax / Taizhou
Note: Product cover images may vary from those shown
Adroll
adroll